Search

Search Constraints

You searched for: Author/Creator Coens, Corneel

Search Results

11. An international phase 3 trial in head and neck cancer: Quality of life and symptom results: EORTC 24954 on behalf of the EORTC head and neck and the EORTC radiation oncology group. Issue 3 (25th October 2013)

12. Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards. Issue 11 (November 2016)

13. Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial. Issue 9 (September 2018)

14. Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling. Issue 1 (29th October 2020)

15. Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative. Issue 3 (February 2015)

16. Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study. (July 2022)

17. Corrigendum to "Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma – Interpretation guidance derived from two randomized EORTC trials" [Lung Cancer 167C (2022) 65–72]. (September 2022)

18. Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma. Issue 8 (1st July 2020)

19. Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol. Issue 1 (10th January 2018)

20. Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients. Issue 8 (18th February 2021)